Related Experiment Video
Updated: Jan 25, 2026

Polarization and Characterization of M1 and M2 Human Monocyte-Derived Macrophages on Implant Surfaces
Published on: December 6, 2024
Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated
Piaopiao Wang1,2, Huihui Wang1,2, Qianqian Huang1,2
1School of Pharmacy, Anhui University of Chinese Medicine, Hefei, Anhui, 230012, China.
Abstract:
Objective: Exosomes (Exos) are membrane-encased vesicles derived by nearly all cell types for intercellular communication and regulation. They also received attention for their use as natural therapeutic platforms and drug delivery system. Classically activated M1 macrophages suppress tumor growth by releasing pro-inflammatory factors. This study investigated the suitability of M1-exosomes (M1-Exos) as drug carrier and their effect on the NF-κB signal pathway and further detected whether macrophages repolarization can potentiate the antitumor activities of chemotherapeutics. Methods: M1-Exos were isolated from M1-macrophages by ultracentrifugation and characterized by transmission electron, nanoparticle tracking analysis, dynamic light scattering and western blot. Then M1-Exos were used as Paclitaxel (PTX) carriers to prepare a nano-formulation (PTX- M1-Exos). A relatively simple slight sonication method was used to prepare the drug delivery system (PTX-M1-Exos). The cytotoxicity of PTX-M1-Exos on cancer cells was detected by MTT and flow cytometry in vitro. 4T1 tumor bearing mice were used to perform the therapeutic effect of PTX-M1-Exos in vivo. Results: The expression of caspase-3 in breast cancer cells was increased when co-incubated with macrophages in the presence of M1-Exos in vitro. The production of pro-inflammatory cytokines was increased after exposure of macrophages in M1-Exos. M1-Exos provided a pro-inflammatory environment which enhanced the anti-tumor activity via caspase-3 mediated pathway. The treatment of M1-Exos to the tumor bearing mice exhibit anti-tumor effects in vivo. Meanwhile, the treatment of PTX-M1-Exos demonstrated higher anti-tumor effects than the M1-Exos or PTX group. Conclusion: The results in our study indicate that the M1-Exos act as the carrier to deliver PTX into the tumor tissues, and also enhance the anti-tumor effects of chemotherapeutics in tumor bearing mice.
Insights
M1-exosomes (M1-Exos) effectively deliver Paclitaxel (PTX) to tumors, enhancing chemotherapy
Area of Science:
- Biomedical Engineering
- Cancer Biology
- Immunology
Background:
- Exosomes (Exos) are crucial for intercellular communication and serve as natural therapeutic platforms.
- Classically activated M1 macrophages release pro-inflammatory factors that suppress tumor growth.
- M1-exosomes (M1-Exos) show potential as drug carriers and modulators of the tumor microenvironment.
Purpose of the Study:
- To investigate M1-exosomes (M1-Exos) as Paclitaxel (PTX) carriers.
- To evaluate the effect of M1-Exos on the NF-κB signaling pathway.
- To determine if macrophage repolarization enhances chemotherapeutic antitumor activity.
Main Methods:
- M1-Exos isolated from M1-macrophages via ultracentrifugation and characterized.
- Paclitaxel-loaded M1-exosomes (PTX-M1-Exos) prepared using sonication.
- Cytotoxicity and antitumor effects assessed using MTT, flow cytometry, and 4T1 tumor-bearing mouse models.
Main Results:
- M1-Exos increased caspase-3 expression and pro-inflammatory cytokine production in cancer cells.
- M1-Exos created a pro-inflammatory environment, enhancing antitumor activity via caspase-3.
- PTX-M1-Exos demonstrated superior antitumor effects compared to M1-Exos or PTX alone in vivo.
Conclusions:
- M1-Exos effectively deliver PTX to tumor tissues.
- M1-Exos enhance the antitumor efficacy of chemotherapeutics.
- Repolarized macrophages via M1-Exos hold promise for cancer therapy.
Related Concept Videos
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Co-activators and Co-repressors
tRNA Activation
Activation Energy
Insensitive Nuclei Enhanced by Polarization Transfer (INEPT)
¹³C NMR: Distortionless Enhancement by Polarization Transfer (DEPT)

